Etofenamate

DB08984InvestigationalSmall molecule

Etofenamate is an NSAID used to treat muscle and joint pain. It is a non-steroidal anti-inflammatory drug (NSAID).

Mechanism: Etofenamate is a topical NSAID that reduces inflammation and pain by inhibiting the cyclooxygenase (COX) pathway and reducing prostaglandin synthesis (non-selective COX inhibition reported).
Curator reviewed · 2 references
Formula / weight: C₁₈H₁₈F₃NO₄ · 369.335 g/mol (avg)
Code names: BAY-D-1107 · TVX-485 · WHR-5020

Resolves to

Compound

UNIIKZF0XM66JCCAS30544-47-9ChEMBLCHEMBL1451633ChEBI94731PubChem35375KEGGD04102

Clinical / RWD

RxNorm24608ATCM02AA06

Structure

InChIKeyXILVEPYQJIOVNB-UHFFFAOYSA-NSMILESOCCOCCOC(=O)C1=CC=CC=C1NC1=CC=CC(=C1)C(F)(F)F

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1,426Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

15Structured indicationsCondition, population, route and combination as fields, not prose

9ContraindicationsEach with its own population and attribute set

66Marketed productsAcross 5 countries and 24 labellers

1ATC codeIncluding every combination product, plus 21 drug categories

5+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Etofenamate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In